Left Atrial Appendage Closure Devices Market Size

Left Atrial Appendage Closure Devices Market Size

The global left atrial appendage closure devices market size was valued at USD 1.8 billion in 2023 and is expected to exhibit growth at a CAGR of 19.2% from 2024 – 2032 period. The growing adoption rate of advanced technologies, and the government policies, among others, are some of the imperative factors that support industry growth.
 

The implantations of left atrial appendage closure techniques are essential for stroke prevention in patients with atrial fibrillation. These techniques can also be used in patients undergoing heart surgery who have atrial fibrillation. A recent study of more than 10,000 records of patients who underwent cardiac surgery indicated that 37% of patient’s had left atrial appendage closure in the U.S. Furthermore, the Watchman device is one that has been investigated extensively and is safe to use after more than 300,000 procedures. Therefore, the procedural success rate is phenomenal. In this manner, it is expected that the market will be propelled due to the enormous potential in left atrial appendage closure devices.
 

Moreover, improvements in the technology of the devices are allowing more people to embrace these procedures globally because of the increased safety and effectiveness of the procedures. There is also increased supply due to a rise in health awareness as well as general adoption of the clinical guidelines of the procedures. There is also an increase in expenditure in the healthcare sector, affordability of modern cardiovascular devices, and more LAA procedures being reimbursed in various countries which are beneficial for market growth globally.
 

Left atrial appendage (LAA) closure devices, or left atrial appendage occlusion devices, aim to mitigate the risk of LAA-originated blood clots entering the systemic circulation and provoking a stroke in patients with a non-valvular atrial fibrillation (AF) condition.